
AxoGen Investor Relations Material
Latest events

Q1 2025
AxoGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AxoGen Inc
Access all reports
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for peripheral nerve injury. It provides Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector that is a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector that is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. The company also offers Avive Soft Tissue Membrane that is a processed human umbilical cord membrane used as a resorbable barrier to separate tissues in repair or reconstruction procedures; and AcroVal Neurosensory & Motor Testing System.
Key slides for AxoGen Inc


Investor Day 2025
AxoGen Inc


Investor Day 2025
AxoGen Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
AXGN
Country
🇺🇸 United States